Pomanda estimates the enterprise value of ELYSIUM HEALTHCARE NO. 2 LIMITED at £171.9m based on a Turnover of £165.9m and 1.04x industry multiple (adjusted for size and gross margin).
Pomanda estimates the enterprise value of ELYSIUM HEALTHCARE NO. 2 LIMITED at £229.7m based on an EBITDA of £29.2m and a 7.86x industry multiple (adjusted for size and gross margin).
Pomanda estimates the enterprise value of ELYSIUM HEALTHCARE NO. 2 LIMITED at £221.5m based on Net Assets of £88.5m and 2.5x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Elysium Healthcare No. 2 LimitedOverview
Elysium Healthcare No. 2 Limited is a live company located in borehamwood, WD6 1JN with a Companies House number of 06244878. It operates in the hospital activities sector, SIC Code 86101. Founded in May 2007, it's largest shareholder is
elysium healthcare holdings 3 limited
with a 100% stake. Elysium Healthcare No. 2 Limited is a established,
mega sized company, Pomanda has estimated its turnover at
£165.9m with
healthy
growth in recent years.
Pomanda's financial health check has awarded Elysium Healthcare No. 2 Limited a 3.5 rating. We use a traffic light system to show it exceeds the industry average on 5 measures and has 3 areas for improvement. Company Health Check FAQs
Health Rating3.5out of 5
5 Strong
3 Regular
3 Weak
Size
annual sales of £165.9m, make it larger than the average company (£4m)
£165.9m - Elysium Healthcare No. 2 Limited
£4m - Industry AVG
Growth
3 year (CAGR) sales growth of 13%, show it is growing at a faster rate (9.4%)
13% - Elysium Healthcare No. 2 Limited
9.4% - Industry AVG
Production
with a gross margin of 30.5%, this company has a comparable cost of product (35.3%)
30.5% - Elysium Healthcare No. 2 Limited
35.3% - Industry AVG
Profitability
an operating margin of 12.5% make it as profitable than the average company (11.2%)
12.5% - Elysium Healthcare No. 2 Limited
11.2% - Industry AVG
Employees
with 2681 employees, this is above the industry average (55)
2681 - Elysium Healthcare No. 2 Limited
55 - Industry AVG
Pay Structure
on an average salary of £36.5k, the company has an equivalent pay structure (£34.9k)
£36.5k - Elysium Healthcare No. 2 Limited
£34.9k - Industry AVG
Efficiency
resulting in sales per employee of £61.9k, this is less efficient (£75.7k)
£61.9k - Elysium Healthcare No. 2 Limited
£75.7k - Industry AVG
Debtor Days
it gets paid by customers after 0 days, this is earlier than average (21 days)
0 days - Elysium Healthcare No. 2 Limited
21 days - Industry AVG
Creditor Days
There is insufficient data available for this Key Performance Indicator!
- - Elysium Healthcare No. 2 Limited
- - Industry AVG
Stock Days
it holds stock equivalent to 0 days, this is less than average (8 days)
0 days - Elysium Healthcare No. 2 Limited
8 days - Industry AVG
Cash Balance
has cash to cover current liabilities
for 0 weeks, this is less cash available to meet short term requirements (29 weeks)
0 weeks - Elysium Healthcare No. 2 Limited
29 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 65.5%, this is a higher level of debt than the average (47.1%)
65.5% - Elysium Healthcare No. 2 Limited
47.1% - Industry AVG
ELYSIUM HEALTHCARE NO. 2 LIMITED financials
EXPORT
Elysium Healthcare No. 2 Limited's latest turnover from June 2024 is £165.9 million and the company has net assets of £88.5 million. According to their latest financial statements, Elysium Healthcare No. 2 Limited has 2,681 employees and maintains cash reserves of £191 thousand as reported in the balance sheet.
Data source:Companies House, Pomanda Estimates
Jun 2024
Jun 2023
Dec 2021
Dec 2020
Dec 2019
Dec 2018
Dec 2017
Dec 2016
Dec 2015
Dec 2014
Dec 2013
Dec 2012
Dec 2011
Dec 2010
Dec 2009
Turnover
165,900,000
207,366,000
113,857,000
102,879,000
88,916,000
79,207,000
79,325,000
65,266,000
49,346,000
46,329,000
42,090,000
40,640,000
44,279,000
47,803,000
46,266,000
Other Income Or Grants
Cost Of Sales
115,374,000
145,026,000
75,537,000
69,006,000
59,579,000
53,086,000
59,096,000
56,192,000
41,816,000
39,019,000
37,367,000
36,853,000
38,654,000
39,169,000
36,989,000
Gross Profit
50,526,000
62,340,000
38,320,000
33,873,000
29,337,000
26,121,000
20,229,000
9,074,000
7,530,000
7,310,000
4,723,000
3,787,000
5,625,000
8,634,000
9,277,000
Admin Expenses
29,872,000
41,504,000
20,670,000
21,607,000
19,029,000
17,779,000
10,666,000
1,547,000
2,190,000
2,178,000
1,547,000
1,368,000
2,506,000
2,260,000
3,168,000
Operating Profit
20,654,000
20,836,000
17,650,000
12,266,000
10,308,000
8,342,000
9,563,000
7,527,000
5,340,000
5,132,000
3,176,000
2,419,000
3,119,000
6,374,000
6,109,000
Interest Payable
2,475,000
3,499,000
2,179,000
2,061,000
1,761,000
1,740,000
1,771,000
7,659,000
10,044,000
10,122,000
10,241,000
10,487,000
10,511,000
9,075,000
10,916,000
Interest Receivable
25,000
1,997,000
99,000
Pre-Tax Profit
18,179,000
17,337,000
15,471,000
10,230,000
8,547,000
6,602,000
9,784,000
15,308,000
-4,704,000
-4,990,000
-7,065,000
-8,068,000
-7,392,000
-2,693,000
-4,796,000
Tax
-2,996,000
80,000
-6,643,000
2,374,000
-3,498,000
-994,000
620,000
227,000
2,765,000
1,090,000
4,302,000
217,000
155,000
-1,027,000
469,000
Profit After Tax
15,183,000
17,417,000
8,828,000
12,604,000
5,049,000
5,608,000
10,404,000
15,535,000
-1,939,000
-3,900,000
-2,763,000
-7,851,000
-7,237,000
-3,720,000
-4,327,000
Dividends Paid
Retained Profit
15,183,000
17,417,000
8,828,000
12,604,000
5,049,000
5,608,000
10,404,000
15,535,000
-1,939,000
-3,900,000
-2,763,000
-7,851,000
-7,237,000
-3,720,000
-4,327,000
Employee Costs
97,764,000
113,613,000
61,007,000
56,379,000
46,785,000
42,421,000
40,673,000
36,299,000
26,666,000
25,571,000
24,185,000
22,669,000
23,816,000
22,070,000
21,305,000
Number Of Employees
2,681
2,397
2,112
1,505
1,993
1,625
1,356
1,328
966
857
805
928
934
847
808
EBITDA*
29,230,000
40,990,000
26,394,000
21,085,000
18,951,000
19,349,000
17,638,000
13,700,000
11,813,000
11,356,000
10,866,000
10,043,000
10,672,000
13,854,000
13,404,000
* Earnings Before Interest, Tax, Depreciation and Amortisation
Jun 2024
Jun 2023
Dec 2021
Dec 2020
Dec 2019
Dec 2018
Dec 2017
Dec 2016
Dec 2015
Dec 2014
Dec 2013
Dec 2012
Dec 2011
Dec 2010
Dec 2009
Tangible Assets
148,114,000
150,920,000
147,083,000
146,163,000
149,405,000
146,833,000
147,270,000
148,999,000
98,591,000
97,784,000
102,178,000
106,351,000
111,597,000
114,971,000
119,326,000
Intangible Assets
7,197,000
8,661,000
10,859,000
12,323,000
13,787,000
15,251,000
16,715,000
18,179,000
21,108,000
29,289,000
29,289,000
21,108,000
22,572,000
24,037,000
25,501,000
Investments & Other
1,000
1,000
Debtors (Due After 1 year)
1,997,000
72,750,000
Total Fixed Assets
155,311,000
159,581,000
157,942,000
158,486,000
163,192,000
162,085,000
165,983,000
239,928,000
119,699,000
127,073,000
131,467,000
127,459,000
134,169,000
139,008,000
144,827,000
Stock & work in progress
262,000
268,000
180,000
172,000
110,000
82,000
77,000
Trade Debtors
54,000
58,000
488,000
7,279,000
3,845,000
4,565,000
7,248,000
7,516,000
4,229,000
3,793,000
3,174,000
2,315,000
2,240,000
4,034,000
5,544,000
Group Debtors
91,412,000
70,017,000
53,972,000
33,935,000
11,456,000
811,000
12,759,000
10,420,000
Misc Debtors
9,045,000
6,241,000
4,684,000
3,381,000
3,739,000
2,710,000
3,725,000
1,038,000
40,000
558,000
976,000
1,032,000
684,000
598,000
604,000
Cash
191,000
102,000
2,295,000
1,682,000
782,000
254,000
2,316,000
4,392,000
32,000
27,000
121,000
18,000
2,697,000
2,773,000
1,323,000
misc current assets
total current assets
100,964,000
76,686,000
61,619,000
46,449,000
19,932,000
7,611,000
13,366,000
12,946,000
4,301,000
4,378,000
4,271,000
3,365,000
6,432,000
20,164,000
17,891,000
total assets
256,275,000
236,267,000
219,561,000
204,935,000
183,124,000
169,696,000
179,349,000
252,874,000
124,000,000
131,451,000
135,738,000
130,824,000
140,601,000
159,172,000
162,718,000
Bank overdraft
Bank loan
Trade Creditors
1,188,000
1,893,000
832,000
434,000
604,000
Group/Directors Accounts
78,770,000
78,770,000
78,770,000
78,770,000
78,770,000
71,723,000
86,771,000
162,469,000
14,963,000
7,900,000
5,753,000
6,638,000
15,792,000
other short term finances
hp & lease commitments
2,188,000
2,084,000
2,162,000
2,252,000
1,865,000
1,727,000
1,600,000
1,701,000
10,752,000
10,488,000
10,243,000
10,003,000
9,760,000
9,519,000
31,000
other current liabilities
3,493,000
4,020,000
4,923,000
3,922,000
5,515,000
4,637,000
3,456,000
6,984,000
2,859,000
2,764,000
3,172,000
4,120,000
5,129,000
8,958,000
8,628,000
total current liabilities
84,451,000
84,874,000
85,855,000
84,944,000
87,338,000
79,980,000
92,659,000
171,154,000
28,574,000
21,152,000
19,168,000
14,123,000
14,889,000
25,549,000
25,055,000
loans
127,000
4,622,000
38,845,000
38,845,000
38,845,000
38,664,000
38,845,000
38,845,000
38,845,000
hp & lease commitments
60,160,000
57,909,000
58,054,000
57,992,000
47,775,000
46,313,000
47,907,000
47,907,000
110,329,000
112,275,000
113,829,000
115,076,000
116,055,000
116,729,000
117,049,000
Accruals and Deferred Income
other liabilities
provisions
23,117,000
20,120,000
19,705,000
14,880,000
13,496,000
13,937,000
14,798,000
15,737,000
14,390,000
17,197,000
18,014,000
total long term liabilities
83,277,000
78,029,000
77,759,000
72,872,000
61,271,000
60,250,000
62,832,000
68,266,000
163,564,000
168,317,000
170,688,000
153,740,000
154,900,000
155,574,000
155,894,000
total liabilities
167,728,000
162,903,000
163,614,000
157,816,000
148,609,000
140,230,000
155,491,000
239,420,000
192,138,000
189,469,000
189,856,000
167,863,000
169,789,000
181,123,000
180,949,000
net assets
88,547,000
73,364,000
55,947,000
47,119,000
34,515,000
29,466,000
23,858,000
13,454,000
-68,138,000
-58,018,000
-54,118,000
-37,039,000
-29,188,000
-21,951,000
-18,231,000
total shareholders funds
88,547,000
73,364,000
55,947,000
47,119,000
34,515,000
29,466,000
23,858,000
13,454,000
-68,138,000
-58,018,000
-54,118,000
-37,039,000
-29,188,000
-21,951,000
-18,231,000
Jun 2024
Jun 2023
Dec 2021
Dec 2020
Dec 2019
Dec 2018
Dec 2017
Dec 2016
Dec 2015
Dec 2014
Dec 2013
Dec 2012
Dec 2011
Dec 2010
Dec 2009
Operating Activities
Operating Profit
20,654,000
20,836,000
17,650,000
12,266,000
10,308,000
8,342,000
9,563,000
7,527,000
5,340,000
5,132,000
3,176,000
2,419,000
3,119,000
6,374,000
6,109,000
Depreciation
7,112,000
17,956,000
7,280,000
7,355,000
7,179,000
9,543,000
6,611,000
6,173,000
6,473,000
6,224,000
6,226,000
6,160,000
6,088,000
6,016,000
5,831,000
Amortisation
1,464,000
2,198,000
1,464,000
1,464,000
1,464,000
1,464,000
1,464,000
1,464,000
1,464,000
1,465,000
1,464,000
1,464,000
Tax
-2,996,000
80,000
-6,643,000
2,374,000
-3,498,000
-994,000
620,000
227,000
2,765,000
1,090,000
4,302,000
217,000
155,000
-1,027,000
469,000
Stock
-6,000
268,000
8,000
62,000
28,000
5,000
77,000
Debtors
24,195,000
76,316,000
14,549,000
25,555,000
11,765,000
-5,695,000
-68,334,000
77,035,000
-82,000
201,000
803,000
-388,000
-13,656,000
823,000
16,568,000
Creditors
-1,188,000
-705,000
1,061,000
832,000
-434,000
-170,000
604,000
Accruals and Deferred Income
-527,000
4,020,000
1,001,000
-1,593,000
878,000
1,181,000
-3,528,000
4,125,000
95,000
-408,000
-948,000
-1,009,000
-3,829,000
330,000
8,628,000
Deferred Taxes & Provisions
2,997,000
20,120,000
4,825,000
1,384,000
-441,000
-861,000
-939,000
1,347,000
-2,807,000
-817,000
18,014,000
Cash flow from operations
4,515,000
-11,374,000
11,020,000
-3,555,000
3,392,000
25,426,000
82,880,000
-57,636,000
11,948,000
11,020,000
31,431,000
9,639,000
20,220,000
12,164,000
6,537,000
Investing Activities
capital expenditure
-4,306,000
-179,735,000
-8,200,000
-4,113,000
-9,751,000
-9,106,000
-4,882,000
-53,652,000
901,000
-1,830,000
-11,698,000
-914,000
-2,714,000
-1,661,000
-152,122,000
Change in Investments
-1,000
1,000
cash flow from investments
-4,306,000
-179,735,000
-8,200,000
-4,113,000
-9,750,000
-9,106,000
-4,883,000
-53,652,000
901,000
-1,830,000
-11,698,000
-914,000
-2,714,000
-1,661,000
-152,122,000
Financing Activities
Bank loans
Group/Directors Accounts
78,770,000
7,047,000
-15,048,000
-75,698,000
147,506,000
7,063,000
2,147,000
5,753,000
-6,638,000
-9,154,000
15,792,000
Other Short Term Loans
Long term loans
-127,000
-4,495,000
-34,223,000
181,000
-181,000
38,845,000
Hire Purchase and Lease Commitments
2,355,000
59,993,000
-28,000
10,604,000
1,600,000
-1,467,000
-101,000
-71,473,000
-1,682,000
-1,309,000
-1,007,000
-736,000
-433,000
9,168,000
117,080,000
other long term liabilities
share issue
55,947,000
66,057,000
-8,181,000
-14,316,000
-13,904,000
interest
-2,475,000
-3,499,000
-2,179,000
-2,036,000
-1,761,000
-1,740,000
226,000
-7,560,000
-10,044,000
-10,122,000
-10,241,000
-10,487,000
-10,511,000
-9,075,000
-10,916,000
cash flow from financing
-120,000
191,211,000
-2,207,000
8,568,000
6,886,000
-18,382,000
-80,068,000
100,307,000
-12,844,000
-9,284,000
-19,630,000
-11,404,000
-17,582,000
-9,061,000
146,897,000
cash and cash equivalents
cash
89,000
102,000
613,000
900,000
528,000
-2,062,000
-2,076,000
4,360,000
5,000
-94,000
103,000
-2,679,000
-76,000
1,450,000
1,323,000
overdraft
change in cash
89,000
102,000
613,000
900,000
528,000
-2,062,000
-2,076,000
4,360,000
5,000
-94,000
103,000
-2,679,000
-76,000
1,450,000
1,323,000
elysium healthcare no. 2 limited Credit Report and Business Information
Very Low Risk70 - 100
Low Risk50 - 70
Moderate Risk30 - 50
High Risk20 - 30
Very High Risk0 - 20
Get a comprehensive credit check for elysium healthcare no. 2 limited. Get real-time insights into elysium healthcare no. 2 limited's credit score, group structure and payment trends.
Perform a competitor analysis for elysium healthcare no. 2 limited by selecting its closest rivals, whether from the HUMAN HEALTH AND SOCIAL WORK ACTIVITIES sector, other mega companies, companies in WD6 area or any other competitors across 12 key performance metrics.
elysium healthcare no. 2 limited Ownership
ELYSIUM HEALTHCARE NO. 2 LIMITED group structure
Elysium Healthcare No. 2 Limited has 1 subsidiary company.
The sole shareholder of Elysium Healthcare No. 2 Limited is Elysium Healthcare Holdings 3 Limited.
elysium healthcare holdings 3 limited
100%
elysium healthcare no. 2 limited directors
Elysium Healthcare No. 2 Limited currently has 4 directors.
The longest serving directors include
Dr Quazi Haque (Dec 2016) and
Mrs Kathryn Murphy (Sep 2020).
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We found 10 charges/mortgages relating to elysium healthcare no. 2 limited. Currently there are 0 open charges and 10 have been satisfied in the past.
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for ELYSIUM HEALTHCARE NO. 2 LIMITED. This can take several minutes, an email will notify you when this has completed.
elysium healthcare no. 2 limitedCompanies House Filings - See Documents
